Evidence map›Paper›PMID 22365605›Full record

ArticleChemistry & biology2012

Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations.

Jennifer E Griffin, Amit K Pandey, Sarah A Gilmore, Valerie Mizrahi, John D McKinney, Carolyn R Bertozzi, Christopher M Sassetti

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Chemistry & biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 193 papers.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 303 citations in OpenAlex.

  1. Trial
  2. Combinatorial metabolic engineering ofSynthetic and systems biotechnology · 2027
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  8. Article
  9. Genome and drug resistance analysis ofFrontiers in microbiology · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inorganic sulfate is critical forProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Jennifer E GriffinDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Amit K Pandey
Sarah A Gilmore
Valerie Mizrahi
John D McKinney
Carolyn R Bertozzi
Christopher M Sassetti
Howard Hughes Medical Institute · USUniversity of Massachusetts Chan Medical School · USÉcole Polytechnique Fédérale de Lausanne · CHUniversity of California, Berkeley · USUniversity of Cape Town · ZA

Funding

Mycobacterial Sulfation PathwaysR01AI051622 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2002 to 2015
$6.0M
Chemical MycobateriologyR37AI051622 · NIAID · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2025
$4.7M
Tuberculosis Pathogenesis and Drug ResponseR01AI064282 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2017
$3.9M
Targets for short-course TB therapy R21AI073509 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2008
$442k
NIAID NIH HHS AI064282NIAID NIH HHS AI073509NIAID NIH HHS AI51622NIAID NIH HHS R01 AI051622NIAID NIH HHS R01 AI064282NIAID NIH HHS R21 AI073509NIAID NIH HHS R37 AI051622
6 · The paper itself

Abstract

To understand the adaptation of Mycobacterium tuberculosis to the intracellular environment, we used comprehensive metabolite profiling to identify the biochemical pathways utilized during growth on cholesterol, a critical carbon source during chronic infection. Metabolic alterations observed during cholesterol catabolism centered on propionyl-CoA and pyruvate pools. Consequently, growth on this substrate required the transcriptional induction of the propionyl-CoA-assimilating methylcitrate cycle (MCC) enzymes, via the Rv1129c regulatory protein. We show that both Rv1129c and the MCC enzymes are required for intracellular growth in macrophages and that the growth defect of MCC mutants is largely attributable to the degradation of host-derived cholesterol. Together, these observations define a coordinated transcriptional and metabolic adaptation that is required for scavenging carbon during intracellular growth.

Indexed as

MetabolomeAcyl Coenzyme AAnimalsBacterial ProteinsCholesterolEnzymesMacrophagesMiceMice, Inbred C57BLMycobacterium tuberculosisPyruvic AcidTranscription, GeneticAcyl Coenzyme ABacterial ProteinsCholesterolEnzymespropionyl-coenzyme APyruvic Acid

Identifiers

PMID22365605
PMCPMC3292763
OpenAlexW2140610868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.